Neos Therapeutics

Neos Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacturing, and commercialization of products using its proprietary extended-release drug delivery technology platform. Adzenys XR-ODT™ is the first and only commercially available extended-release orally disintegrating tablet (ODT) of amphetamine for the treatment of ADHD. Neos is developing two additional branded product candidates: an XR-ODT formulation of methylphenidate and an amphetamine liquid suspension for the treatment of ADHD. Additionally, Neos manufactures and markets a generic version of its branded product Tussionex® 1, an extended-release liquid suspension of hydrocodone and chlorpheniramine used to relieve cough and upper respiratory symptoms associated with the common cold.